Qilu Pharmaceutical

Qilu Pharmaceutical Co., Ltd., located in Jinan, Shandong Province, is a large-scale pharmaceutical backbone enterprise in China with a development history of fifty years. Originally known as Qilu Pharmaceutical Factory, the company primarily engages in the research, production, and sales of formulations and active pharmaceutical ingredients for treating tumors, cardiovascular and cerebrovascular diseases, infections, neurological and psychiatric disorders, respiratory conditions, digestive system ailments, and eye diseases. Qilu Pharmaceutical has consistently adhered to an innovation-driven development strategy, focusing on market demand as its core and product innovation as its guiding principle. It actively expands domestic and international research and development collaborations, emphasizing talent recruitment and cultivation. The company has built a high-quality scientific research team with professional and efficient R&D capabilities, establishing a rational pipeline of products under development for the company's future growth. This includes dozens of small molecule drugs with novel molecular structures, new drug formulations, recombinant proteins, synthetic peptides, and anticancer vaccines, all of which are at various stages of development, including clinical research.